期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

microRNAs在肿瘤干细胞中的研究进展 被引量：2

Advances of microRNAs in cancer stem cells
下载PDF
导出
摘要 microRNAs(miRNAs)是一类非编码的小RNA,在肿瘤发生发展及侵袭转移中发挥着至关重要的作用。肿瘤干细胞是导致恶性肿瘤复发、转移和耐药的主要根源。研究发现miRNAs可以促进或抑制肿瘤干细胞"干性"的维持,调控肿瘤干细胞的分化及自我更新,从而参与肿瘤的发生发展过程。本文详细介绍了肿瘤干细胞中miRNAs的表达情况及调控机制,阐述其在肿瘤诊断及治疗中的潜在作用。 microRNAs （miRNAs） are a class of non-coding RNAs that are believed to play important roles during tumorigene sis and cancer metastasis. Cancer stem cells are a major source leading to tumor recurrence, metastasis and drug resistance. Resear ches reported that miRNAs could promote or inhibit the stemness of cancer stem cells, regulate the differentiation and self-renewal process of cancer stem ceils. The purpose of this paper is to describe the phenotype and regulation mechanism of miRNAs in cancer stem cells, and explain its potential role in tumor diagnosis and treatment.
作者 杨瑞娜 王新帅 高社干
机构地区 洛阳河南科技大学第一附属医院肿瘤内五科
出处 《临床肿瘤学杂志》 CAS 2013年第12期1141-1144,共4页 Chinese Clinical Oncology
关键词 microRNAs(miRNAs) 肿瘤干细胞 干性 microRNAs（miRNAs） Cancer stem cells Stemness
分类号 R730.51 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献23

  • 1Barrel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
  • 2Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 3Johnson SM, Grosshans H, Shingara J, et al. R.AS is regulated by the let-7 microRNA family. Cell 2005; 120:635-647.
  • 4Michael MZ, O'Connor SM, van Hoist Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1:882-891.
  • 5Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065- 7070.
  • 6Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.
  • 7Gaur A, Jewell DA, Liang Y, et al. Characterization ofmicroRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67:2456-2468.
  • 8Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-838.
  • 9Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103:9136-9141.
  • 10Miller A J, Mihm MC Jr. Melanoma. N Engl J Med 2006; 355:51- 65.

共引文献44

同被引文献23

  • 1Shan GY, Zhang Z, Chen QG, et al. Overexpression of RIN1 as- sociates with tumor grade and progression in patients of bladder urothelial carcinoma [ J ]. Tumour Biol, 2012, 33 ( 3 ) : 847-855.
  • 2Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers [ J ]. Brit J Cancer, 2010, 102(7): 1174-1179.
  • 3Li BS, Zhao YL, Guo G, et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection [ J/OL ]. PLoS One, 2012, 7 (7) [ 2014-02- 18 ]. http://www, ncbi. nlm. nih. gov/pmc/articles/ pmid/22860003.
  • 4Karaayvaz M, Zhang C, Liang S, et al. Prognostic significance of miR-205 in endometrial cancer[ J/OL. PLoS One, 2012, 7 (4) [ 2014-10-21 ]. http://www, ncbi. nlm. nih. gov/pmc/ articles/PMC3325973.
  • 5Ineoronato M, Urso L, Portela A, et al. Epigenetic regulation of miR-212 expression in lung cancer[ J/OL]. PLoS One, 2011, 6 ( ll ) [ 2014-08-11 ]. http://www, ncbi. nlm. nih. gov/pmc/ articles/PMC3216999.
  • 6Zhu W, He J, Chen D, et al. Expression of miR-29 e, miR-93, and miR-429 as potential biomarkers for deteetion of early stagenon-small lung cancer[ J/OL ]. PLoS One, 2014, 9 (2) [ 2014- 10-22 ]. http ://www. ncbi. nlm. nih. gov/pmc/articles/PMC3921- 142.
  • 7Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis[ J]. Mol Carcinog, 2011, 50(2) : 136-142.
  • 8Yartg M, Chert J, Su F, et al. Microvesicles secreted by macro- phages shuttle invasion-potentiating microRNAs into breast cancer cells[J]. Mol Cancer, 2011, 10: 117.
  • 9Fang L, Du WW, Yang W, et al. MiR-93 enhances angiogenesis and metastasis by targeting LATS2[ J]. Cell Cycle, 2012, 11 ( 23 ) : 4352- 4365.
  • 10Vosgha H, Sajegheh A, Smith RA, et al. The important roles of miR-205 in normal physiology, cancers and as a potential thera- peutic target[ J]. Curr Cancer Drug Targets, 2014, 14(7) :621 - 637.

引证文献2

二级引证文献10

临床肿瘤学杂志
2013年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部